Drug Shortage Report for INTUNIV XR

Last updated on 2019-09-27 History
Report ID 91467
Drug Identification Number 02409135
Brand name INTUNIV XR
Common or Proper name guanfacine hydrochloride extended-release tablets
Company Name TAKEDA CANADA INC
Market Status MARKETED
Active Ingredient(s) Guanfacine
Strength(s) 4MG
Dosage form(s) TABLET (EXTENDED-RELEASE)
Route of administration ORAL
Packaging size 100 Tablets / Bottle
ATC code C02AC
ATC description ANTIADRENERGIC AGENTS, CENTRALLY ACTING
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2019-08-13
Actual start date
Estimated end date 2019-09-30
Actual end date 2019-09-26
Shortage status Resolved
Updated date 2019-09-27
Company comments Shortage resolved as of 26Sep2019
Health Canada comments
Tier 3 Status No
Contact Address 22 ADELAIDE STREET WEST
TORONTO, ONTARIO
CANADA M5H 4E3
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v11 2019-09-27 English Compare
v10 2019-09-26 French Compare
v9 2019-09-26 French Compare
v8 2019-09-26 English Compare
v7 2019-08-15 French Compare
v6 2019-08-15 English Compare
v5 2019-08-15 English Compare
v4 2019-08-14 English Compare
v3 2019-08-13 French Compare
v2 2019-08-13 French Compare
v1 2019-08-13 English Compare

Showing 1 to 11 of 11